Your session is about to expire
← Back to Search
Zevalin + Chemotherapy and Stem Cell Transplant for Non-Hodgkin's Lymphoma (Zevalin Trial)
Zevalin Trial Summary
This trial is testing a new cancer treatment that combines a targeted radiation therapy with high-dose chemotherapy and stem cell transplantation.
Zevalin Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowZevalin Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Find a Location
Who is running the clinical trial?
Media Library
- I have severe lung function issues or need constant oxygen.I have been diagnosed with lymphoma in my central nervous system.I am not pregnant, breastfeeding, and I use effective birth control.I am able to get out of my bed or chair and move around.I am between 18 and 70 years old.I have previously undergone radioimmunotherapy.I am currently fighting an infection.My liver tests are not normal.My kidney function is not normal, with high creatinine levels.My heart's pumping ability is below 40%.I have not had intense radiation to my bone marrow or critical organs.My lymphoma is advanced, has returned or didn't respond to treatment, and tests positive for CD20.I have had a specific type of stem cell collected for treatment.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is enrollment for this study still open?
"As per clinicaltrials.gov, this trial is not presently seeking participants; it was initially posted in March 2007 and most recently edited several weeks ago. However, there are currently 1778 other studies looking for enrolment right now."
Does this research open its doors to elderly participants?
"The requirements to participate in this trial dictate that individuals must be between the age of 18 and 70."
Who is authorized to participate in this investigation?
"40 individuals between the ages of 18 and 70, who are presently suffering from lymphoma may be eligible for enrolment in this trial. Further qualifications include being within an Eastern Cooperative Oncology Group (ECOG) performance score range of 0 to 2."
Has this medicine attained sanction from the Federal Drug Administration?
"The safety of this treatment has been assessed as a 2, since Phase 2 trial data only exists to suggest its security but not yet its effectiveness."
Share this study with friends
Copy Link
Messenger